These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 4674091)

  • 1. Participation of nonspecific factors in destruction of type M 12 streptococci in vitro. IV. Detailed characteristics of nonspecific cofactor and its streptococcal receptor.
    Kahlich R; Procházka O; Dubanská H
    J Hyg Epidemiol Microbiol Immunol; 1972; 16(4):412-25. PubMed ID: 4674091
    [No Abstract]   [Full Text] [Related]  

  • 2. Participation of nonspecific factors in the destruction of type M 12 streptococcus in vitro. I. Nonspecific absorption of anti-M 12 bactericidal activity.
    Kahlich R; Procházka O
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(1):75-87. PubMed ID: 4985648
    [No Abstract]   [Full Text] [Related]  

  • 3. Participation of nonspecific factors in destruction of type M12 streptococci in vitro. 3. A highly sensitive modification of the bactericidal test. Nonspecific coopsonin requirements.
    Kahlich R; Procházka O
    J Hyg Epidemiol Microbiol Immunol; 1971; 15(4):375-88. PubMed ID: 5170796
    [No Abstract]   [Full Text] [Related]  

  • 4. Complex surveillance of Streptococcus pyogenes. III. Immunological characteristics of streptococcal resistance in blood and new aspects of type nonspecific protection.
    Kahlich R
    J Hyg Epidemiol Microbiol Immunol; 1976; 20(1):61-75. PubMed ID: 772126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Participation of nonspecific factors in the destruction of type M12 streptococci in vitro. II. Indispensability of human complement and role of other factors in the bactericidal test.
    Kahlich R
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(2):172-83. PubMed ID: 5463710
    [No Abstract]   [Full Text] [Related]  

  • 6. [Detection of type-specific streptococcal M-antibodies in the indirect bactericidal test by use of monkey blood].
    Köhler W; Djikidse EK
    Zentralbl Bakteriol Orig A; 1972 Aug; 221(3):309-13. PubMed ID: 4146471
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibody to streptococcal opacity factor in human sera.
    Maxted WR; Widdowson JP; Fraser CA
    J Hyg (Lond); 1973 Mar; 71(1):35-42. PubMed ID: 4511948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex surveillance of streptococcus pyogenes. VI. Relationship between hypersensitivity to zymosan and indicators of immunity against group A streptococci.
    Kahlich R; Svec M; Procházka O
    J Hyg Epidemiol Microbiol Immunol; 1983; 27(2):219-28. PubMed ID: 6350449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex surveillance of Streptococcus pyogenes. I. Immunological surveys of anti-M antibodies and possibilities of long-term epidemiological prognosis.
    Kahlich R; Kotlár V; Skocil V
    J Hyg Epidemiol Microbiol Immunol; 1975; 19(1):48-60. PubMed ID: 1092756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody structure: amino terminal sequences of nurse shark light and heavy chains.
    Sledge C; Clem LW; Hood L
    J Immunol; 1974 Mar; 112(3):941-8. PubMed ID: 4811970
    [No Abstract]   [Full Text] [Related]  

  • 11. Isoelectric focusing of proteolytic fragments from rabbit anti-streptococcal antibodies of restricted heterogeneity.
    Vienne A; Wikler M
    FEBS Lett; 1974 Feb; 39(2):160-3. PubMed ID: 4604638
    [No Abstract]   [Full Text] [Related]  

  • 12. Purified group a streptococcal M-protein in latex agglutination for detection of type-specific M-antibodies.
    Erwa HH
    Afr J Med Sci; 1973 Oct; 4(4):479-90. PubMed ID: 4792061
    [No Abstract]   [Full Text] [Related]  

  • 13. Protective study with a group A streptococcal M protein vaccine. Infectivity challenge of human volunteers.
    Fox EN; Waldman RH; Wittner MK; Mauceri AA; Dorfman A
    J Clin Invest; 1973 Aug; 52(8):1885-92. PubMed ID: 4719668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of type specific streptococcal antibodies by in vitro phagocytosis.
    Bergner-Rabinowitz S; Beck A; Ofek I; Davies AM
    Isr J Med Sci; 1969; 5(3):285-92. PubMed ID: 5821820
    [No Abstract]   [Full Text] [Related]  

  • 15. Natural antibodies in man to Streptococcus mutans: specificity and quantification.
    Challacombe SJ; Bergmeier LA; Czerkinsky C; Rees AS
    Immunology; 1984 May; 52(1):143-50. PubMed ID: 6715017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on streptococcal T antibodies. I. Basic studies on hemagglutination reaction for determination of streptococcal T antibodies (author's transl)].
    Takizawa Y; Takase A; Tomizawa I; Konishi K
    Kansenshogaku Zasshi; 1982 Jan; 56(1):37-46. PubMed ID: 6806410
    [No Abstract]   [Full Text] [Related]  

  • 17. Sequence variations in b9 light chains as potential V region genetic markers.
    Thunberg AL; Lackland H; Kindt TJ
    J Immunol; 1973 Dec; 111(6):1755-64. PubMed ID: 4750866
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dynamics of the antibody response to streptococcal antigens in spontaneous group A beta-hemolytic streptococcus infections (scarlet fever)].
    Medina F
    Prog Immunobiol Stand; 1970; 4():597-600. PubMed ID: 4991593
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on group A streptococcal M-proteins: purification of type 5 M-protein and comparison of its amino terminal sequence with two immunologically unrelated M-protein molecules.
    Manjula BN; Fischetti VA
    J Immunol; 1980 Jan; 124(1):261-7. PubMed ID: 6985640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of specific antibodies in anti-Escherichia coli donor plasma and of its isolated immunoglobulins].
    Arkhipov NA; Golodnenkova VN; Krokhina MA; Temner RM; Moshiashvili IIa
    Probl Gematol Pereliv Krovi; 1981 Mar; 26(3):45-7. PubMed ID: 7015315
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.